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Abstract 
Objective: Type D personality is characterised by negative affectivity and social inhibition, and is 
often associated with poorer physical and psychological health. However, the underlying mechanisms 
are unclear and the literature lacks longitudinal assessment. We aimed to prospectively examine the 
relationships between Type D and physical symptoms, in addition to retrospective health. 
Design: An online questionnaire-based study (N=535) with a one-year follow-up (N=160) was 
conducted with healthy individuals (18-65years). Type D was assessed as a categorical and dimensional 
construct. 
Main Outcome Measures: Participants completed Type D scale-14, Hospital Anxiety and 
Depression Scale, Cohen-Hoberman Inventory of Physical Symptoms and Perceived Stress Scale at both 
phases. Retrospective health questions and Social Readjustment Rating Scale were completed at follow-
up.  
Results: Type D was related to cardiac/sympathetic, metabolic, vasovagal, muscular, and 
headache symptoms at baseline. At follow-up stressful events and anxiety mediated the relationships 
between Type D and particular symptoms. Type Ds were more likely to report poorer health, and 
increased minor illnesses, work absences, and medical-information-seeking. 
Conclusions: Type D is associated with stress-related symptoms. Although the relationships are 
primarily driven by NA, this supports the theory of a stress-related mechanism. These findings 
contribute to the literature highlighting Type D as a risk factor for poor health. 
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Introduction 
Type D personality is characterised by the interaction of negative affectivity (NA) and social 
inhibition (SI) (Denollet, 2000). Type D individuals have the tendency to experience negative emotions 
including dysphoria, anger, anxiety, hostility, and general distress across situations and time, whilst also 
inhibiting the expression of these emotions in social situations due to fear of rejection or disapproval 
(Denollet, 1998b; Mols & Denollet, 2010a). 
Since its initial proposal the prognostic validity of the Type D construct has been demonstrated in 
cardiac patient populations. However, there is accumulating evidence that Type D may be an important 
risk factor for poor health in other illness groups (Mols & Denollet, 2010a), as well as in otherwise 
‘healthy’ individuals (Smith et al., 2018; Williams & Wingate, 2012), that is, individuals who are free 
from any chronic conditions. Existing research has established Type D as a predictor of poorer physical 
health, including increased somatic symptoms, general health complaints and immune related illnesses 
(Condén, Leppert, Ekselius, & Åslund, 2013; Stevenson & Williams, 2014; Williams & Wingate, 2012).  
Early estimates suggest that Type D personality was prevalent in 20% of the general population 
(Denollet, 2005). However, recent studies have estimated prevalence of up to 42.8% (Booth & Williams, 
2015), which further exemplifies the importance of researching the health effects of Type D in ‘healthy’ 
populations 
Type D has also been associated with increases in anxiety, depression, somatisation (Michal, 
Wiltink, Grande, Beutel, & Brähler, 2011), maladaptive stress reactivity (Habra, Linden, Anderson, & 
Weinberg, 2003; Howard & Hughes, 2013; Kelly-Hughes, Wetherell, & Smith, 2014; O’Leary, Howard, 
Hughes, & James, 2013), dysfunctional coping strategies, lower social support (Williams & Wingate, 
2012), and adverse health behaviours (Booth & Williams, 2015) in the general population. Accordingly, 
these are all factors which may potentially mediate the relationship between Type D and physical health 
(Howard, Hughes, & James, 2011; Williams & Wingate, 2012). The relationship between Type D and 
health in the general population is beginning to receive more attention, and in a recent study, has been 
found to be mediated by anxiety and perceived stress (Smith et al., 2018). However, prospective 
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examination is required to further understand the mechanisms underpinning the now well-documented 
relationship. 
Type D personality is traditionally assessed categorically, with individuals scoring above a 
particular threshold on both SI and NA being classified as Type D (Denollet, 2005). Although this 
approach is useful, it has also been criticised for not accurately representing the interactive effect of SI 
and NA, and typologies generated from two continuous variables in this way, have been criticised 
(Coyne et al., 2011). Consequently, Ferguson et al., (2009) has recommended that Type D may be better 
conceptualised as a dimensional variable. Therefore, in line with previous studies (e.g. Stevenson & 
Williams, 2014), Type D will be considered as both a categorical and a continuous variable within the 
current study.  
Given previous findings linking Type D to a range of health outcomes including; poor prognosis in 
heart disease patients (Kupper & Denollet, 2007); cancer survivors (Mols, Denollet, Kaptein, Reemst, & 
Thong, 2012) and other clinical populations (Mols & Denollet, 2010a) as well as increased physical 
symptoms (Smith et al., 2018; Williams & Wingate, 2012), it appears necessary to assess the extent to 
which Type D personality may predict physical health over time. Moreover, there is a notable lack of 
longitudinal evidence to support the predictive value of Type D personality on health in the general 
population. This makes it difficult to reliably infer cause and effect, and limits the capacity to investigate 
potential mediating mechanisms (Maxwell & Cole, 2007). Therefore, a longitudinal assessment of the 
associations between Type D personality and physical symptoms, in addition to aspects of general 
health status and healthcare utilization, is warranted.  
In light of the accumulating evidence with respect to the role of stress and distress in the Type D-
health relationship (e.g. Smith et al., 2018) this study will examine the potential mediating effects of 
stress, anxiety and depression. The current study aims to contribute to our understanding of the 
pathways underpinning the relationship between Type D personality and the manifestation of physical 
symptoms. In light of the current Type D literature it is hypothesised that: 
i) Type D personality will be linked to increased reporting of physical symptoms 
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ii) Stress, anxiety and depression will play a mediating role in the relationships 
between Type D and physical symptoms 
iii) Type D personality will be related to poorer retrospective health outcomes, and 
decreases in healthcare utilisation due to their social inhibition 
Method 
Participants and Procedure 
An online questionnaire based study was conducted with 535 healthy individuals (18-65 years).  
Participants were recruited online via social media platforms, student participation pools and via email 
within the researcher’s institution. Of the baseline sample (N = 535), 293 participants consented to 
being contacted for the follow-up, and were sent an email invitation to the follow-up one year later 
(within one week of the date they completed baseline). At follow up, 160 participants took part within 
30 days of email invitation receipt (M=5.45 days). The majority of participants were from the UK 
(90.09%), however due to the online nature of the study participants resided worldwide (non-UK Europe 
[2.43%]; North and South America [3.93%], Australia [1.50%] and Asia [1.68%]). 
Exclusion criteria stipulated that individuals with a history of psychological health issues, known 
chronic or immune related illnesses, and diagnosed sleep disorders should refrain from taking part 
(including those diagnosed in the year between baseline and follow up). Course credit was given to 
those participants who were students at baseline, but no remuneration was offered at follow up. 
Information regarding reasons for non-participation was not collected. 
Full study information was presented to participants via the Qualtrics platform at the beginning 
of each study phase and was accessed via the URLs provided. Informed consent was gained online via a 
multiple-choice selection and an option to provide an email address (to be contacted for the follow-up) 
was given at baseline. At each study phase participants provided date of birth and gender to ensure 
accurate matching of data. At baseline participants completed online versions of the DS14, CHIPS, PSS 
and HADS. At follow-up participants completed the DS14, CHIPS, PSS, and HADS a second time, in 
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addition to the SRRS and retrospective health questions (see Appendix 1). An online debrief was 
presented to participants at the end of each session. The study and its protocol were approved by the 
relevant institutional ethics committee prior to data collection. 
Analyses revealed that individuals who took part in the follow up (Mage = 34.05, SD= 13.71) were 
significantly older than those who did not (Mage=28.00, SD= 12.13), t (533) = -5.073, p<.001. Chi squared 
analyses indicated no significant association i) between gender and follow-up status X² (1) =.865, p= .35, 
or ii) between Type D and follow-up status X² (1) =.034, p= .85. Participants’ demographic and Type D 
data for each study phase are displayed in table 1. 
TABLE 1 HERE 
Materials 
Type D scale- 14 
Type D personality was assessed using the Type D Scale-14 (DS-14) (Denollet, 2005). The DS14 is 
a brief psychometrically sound measure of NA and SI, the combination of which is described as Type D 
personality. The instrument comprises a 7-item subscale measuring NA (e.g. ‘I often feel unhappy’) and 
a 7-item subscale measuring social inhibition (e.g. ‘I often feel inhibited in social situations’). In initial 
validation studies (Denollet, 2005) both the NA and SI scales were found to be internally consistent (α= 
0.88 and α= 0.86), and stable over a 3-month period (r=0.72 and r=0.82). 
In line with traditional categorical assessment of Type D individuals scoring 10 or above on scales 
were classified as Type D.  In order to analyse Type D as a dimensional construct a continuous measure 
was computed using the arithmetic product of SI and NA scores (SI*NA). Both methods were used in 
analyses as recommended by Stevenson & Williams (2014). 
Cohen-Hoberman Inventory of Physical Symptoms 
The Cohen-Hoberman Inventory of Physical Symptoms (CHIPS; Cohen & Hoberman, 1983) was 
used as the main outcome measure. The CHIPS is a list of 33 common physical symptoms (e.g. ‘back 
pain’; ‘diarrhoea’) rated on a 5-point Likert scale ranging from (0) ‘not been bothered by the problem’ 
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to (4) ‘extremely bothered by the problem’ (during the previous 2 weeks). The total score is the sum of 
the responses on the 33 items (possible score range 0-132). Cronbach’s alpha for the overall CHIPS scale 
was .92, indicating good internal consistency.  
The factor structure of the CHIPS has recently been examined (Allen, Wetherell, & Smith, 2017) 
and  8 ‘symptom clusters’ were identified as follows: ‘sympathetic/cardiac’ (7 items); muscular pain (6 
items); ‘metabolic symptoms’ (5 items); ‘gastrointestinal’ (5 items);  ‘vasovagal symptoms’ (4 items);  
‘cold/flu’ (2 items); ‘headache’ (2 items); and ‘minor haemorrhagic symptoms’ (2 items). Each cluster 
was considered individually within the current study, with the exception of haemorrhagic symptoms, 
given the low internal consistency of this factor (Allen et al., 2017). 
Perceived Stress Scale 
Subjective stress was measured using the Perceived Stress Scale (PSS; Cohen, Kamarck, & 
Mermelstein, 1983). The PSS is a 10-item scale (α= 0.85) that assesses how respondents have 
experienced and dealt with stressful situations in the past month. Response choices are on a 5-point 
Likert scale and range from (0) “never” to (4) “very often” and a number of items are reverse scored. 
Scores are calculated by summing the 10 item ratings, and range from 0 to 40, with higher scores 
indicating higher levels of perceived stress.  
Hospital Anxiety and Depression Scale 
Levels of anxiety and depression were examined using the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983). The HADS comprises 14 items with answers coded between 0 and 3 
(positively worded items are reversed scored). 7 items measure anxiety (α= 0.83) and 7 items measure 
depression (α=0.82), a separate score is derived for each scale with higher scores indicating higher levels 
of anxiety and depression, respectively. 
Social Readjustment Rating Scale 
The Social Readjustment Rating Scale (SRRS; Holmes & Rahe, 1967) assessed the number of 
stressful life events experienced over the past year. The scale comprises 42 items weighted by impact 
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(e.g. 100 points for death of a spouse, 11 points for minor violations of the law). The sum of the weighted 
items is calculated to give a total score for each participant. 
Retrospective Health Questions 
A number of retrospective health questions (see Appendix 1) were included in the follow-up. 
These comprised of 11 questions with 5- point multiple-choice responses. Questions covered 
perceptions of general health (e.g. how do you rate your current general health); frequencies of illness 
(how often have you suffered a non-serious illness?); use of healthcare services (how often have you 
visited your GP or other healthcare professional?); and seeking of medical advice (how often have you 
sought advice about health problem?). Example responses were categorical including scales of 
frequency (e.g. ‘never’ to ‘often’) and perceptions of quality (e.g. ‘very good’ to ‘very poor’).  
Treatment of data 
 At baseline, all 535 participants completed the DS14, CHIPS and HADS; however, 11 participants 
did not complete the PSS. Therefore, for perceived stress at baseline only 524 cases were included in 
analyses. At follow up, all 160 participants completed all scales. Outliers greater than 3SDs above or 
below the mean were removed from the data (Osborne & Overbay, 2004) to ensure no extreme cases 
skewed the results. This resulted in minimal loss of data (1 Type D score [SI*NA] at baseline and 2 at 
follow-up). The remainder of the participants’ data was included in analyses. 
A power analysis was calculated using G*power 3.1. This indicated a sample size of n=125 would 
result in adequate power (0.803) for a small effect (f2= 0.10) and n=85 for a medium effect (f2=0.15). 
Primary analyses comprised of independent samples t-tests to examine differences between Type 
D and non-Type D individuals on physical symptoms, anxiety, depression, and perceived stress. 
Pearson’s correlations between the continuous Type D construct at baseline and the physical symptoms 
and psychological variables were also undertaken. Hierarchical multiple regression analyses controlling 
for the separate influences of SI and NA in step 1 were also conducted to determine whether Type D (SI 
x NA) at baseline had a significantly greater predictive value than that of NA and SI considered separately 
on physical symptoms at baseline. 
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Mediation analyses using the PROCESS macro for SPSS (Hayes & Preacher, 2013) were then used 
to examine if perceived stress, anxiety, depression, or stressful life events mediated the relationship 
between Type D and physical symptoms at follow up. Each mediator and outcome variable was entered 
into a separate model for analysis, and in line with recommendations for longitudinal research 
(Fitzmaurice, Laird, & Ware, 2012), baseline symptoms were entered as covariates into each model. This 
analysis was performed using the recommended 5,000 bootstrap resamples. In order to assess whether 
the potential mediators fully mediated the relationship between Type D and physical symptoms, the 
following conditions were required: i) the bootstrapped confidence intervals relating to the indirect 
effect must not overlap with 0, and ii) the direct effect when the mediator was included (Figure 1, path 
c’) needed to become non-significant. In the case that only the first condition was met, then it could be 
concluded that partial mediation had occurred.  The direct effect shows the direct relationship between 
Type D personality and CHIPS scores via path c’ when each mediator is included in the model. The 
indirect effect shows the indirect relationship between Type D personality and CHIPS scores via each 
mediator (i.e. path a*b).  The bootstrap mediation analyses performed are represented in Figure 1. 
 
FIGURE 1 HERE 
Results 
Temporal stability  
Paired samples t-tests indicated no significant differences between scores at baseline with scores 
at follow up on the measures of negative affect; t(159)=-0.333), p=.74, d=.053, social inhibition; 
t(159)=1.032 , p=.30, d=.175, or Type D (SI × NA); t(157)= 0.916 , p=.36, d=.145. Pearson’s correlations 
analyses demonstrated strong correlations between baseline and follow-up scores; (SI; r= .857**, NA; 
r=.837**, Type D; r=.828**) indicating the DS14 exhibited excellent test-retest reliability, and stability 
over the year period. Consequently, for the purpose of the current study Type D scores and 
categorisation determined at baseline were used for the remaining analyses. 
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Test-retest correlations of SI, NA, Type D, anxiety, depression, perceived stress and total physical 
symptoms between baseline and follow up can be observed in table 2.  
TABLE 2 HERE 
Anxiety, depression and stress 
As shown in Table 3, Type D participants reported significantly greater levels of anxiety, 
depression, and perceived stress at baseline (N=535) compared with non-Type D participants. These 
findings were supported by Pearson’s correlational analyses, which indicated significant positive 
correlations between SI, NA, and total Type D (NA × SI) scores with anxiety, depression, and perceived 
stress at baseline.  
TABLE 3 HERE 
Physical symptoms 
Type D participants reported significantly more physical symptoms than non-Type D participants 
at baseline across all symptom clusters. Pearson’s correlational analyses indicated significant positive 
correlations between SI scores (at baseline) and physical symptoms, with the exception of 
gastrointestinal symptoms. NA scores and total Type D score (NA × SI) demonstrated significant positive 
correlations with all symptoms (see Table 3). 
Multiple regression analyses (see Table S1) showed NA was a significant predictor of total 
symptoms at Step 1, with the overall regression model predicting a significant 20% of the variance in 
physical symptoms; F(2, 522) = 65.35, p< .001, ƞp²=.200. The overall regression model was also 
significant at Step 2; F(3, 522)= 47.03, p< .001, ƞp²=.212 and the Type D interaction term significantly 
predicted an additional 1.3% variance.  
With respect to sympathetic/cardiac symptoms, NA was the only significant predictor at Step 1, 
accounting for 7.8% of the variance within a significant regression model; F(2, 522) = 22.112, p< .001, 
ƞp²=.078. The model was also significant at Step 2; F(3, 521) = 16.834, p< .001, ƞp²=.082, and Type D 
significantly predicted an additional 1.0% of the variance. NA was also a significant predictor of muscular 
symptoms at Step 1 within a significant model F(2, 522) = 25.63, p< .001, ƞp²=.073, explaining 8.9% of 
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the variance. Type D accounted for an additional 0.6% of the variance, but this was not significant. NA 
was again the only significant predictor in the model for vasovagal symptoms; F(2, 522) = 31.67, p< .001, 
ƞp²=.108, explaining 10.9% of the variance. At step 2, the model remained significant; F(3, 521) = 24.21, 
p< .001, ƞp²=.122, and Type D significantly predicted an additional 1.4% of the variance. Similarly, for 
headaches, 11.1% of the variance was accounted for in step 1, with NA the only significant predictor in 
the model; F(2, 522) = 32.47, p< .001, ƞp²=.111. At step 2 the model remained significant; F(3, 521) = 
25.72, p< .001, ƞp²=.123, and Type D explained an additional 1.4% of the variance. NA was also a 
significant predictor of cold/flu symptoms at Step 1 within a significant model, F(2,522) = 12.64, p< .001, 
ƞp²=.046, and explained 4.6% of the variance. The model was also significant at Step 2; F(3, 521) = 8.65, 
p< .001, ƞp²=.047, however, Type D did not significantly predict any additional variance.  
Mediating pathways 
All symptom clusters at baseline significantly predicted the respective cluster at follow up (all p 
values ≤ .001). Type D was significantly related to the four mediating variables (path a); anxiety, 
depression, perceived stress (all p values ≤ .001), and stressful life events (p=.040). As shown in table 4, 
Type D personality was found to be a significant predictor of metabolic, cold/flu, and gastrointestinal 
symptoms (path c) one year later when baseline scores were controlled (total effect). 
TABLE 4 HERE 
Table 5 shows mediation analyses for the relationships between baseline Type D personality and 
metabolic; gastrointestinal; and cold/flu symptoms at follow up, via each of the mediating variables. 
TABLE 5 HERE 
The indirect effect (a*b) of Type D on metabolic symptoms (whereby the bootstrapped 
confidence interval for the indirect effect did not include 0) via both anxiety (BaC CI [.0017, .0070]) and 
stressful life events (BaC CI [.0001, .0020]) was significant. The direct effect (path c’) became non-
significant when considered through the anxiety pathway (p=.130) indicating full mediation, and 
remained significant through the stressful life events pathway (p=.015) indicating partial mediation.  
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With respect to gastrointestinal symptoms, the indirect effect (a*b) of baseline Type D via 
stressful life events (BaC CI [.0001,.0014]) was significant, and stressful life events were found to 
partially mediated this relationship (the direct effect remained significant; p=.006). No mediating effects 
of, depression, anxiety and perceived stress were observed. Finally, no mediating effects of any of the 
variables were observed in the relationship between Type D and cold/flu symptoms 
Retrospective Health  
Perceived general health  
Type D category was significantly related to i) perceptions of current general health (X² (4) 
=13.765, p=.004.), ii) perceptions of health over the past 12 months (X² (4) =11.637, p=.012) and iii) 
satisfaction with current health status (X² (4) =9.321, p=.046). Type Ds were more likely to rate their 
current general health as ‘fair’, their health over the past year as ‘not very good’, and be dissatisfied’ 
with their current health status. Type Ds were also less likely to provide ratings of ‘very good’ for these 
questions. However, there were no differences in how participants compared their current health status 
to one year earlier (X² (4) =7.299, p=.099).  
Frequency of illnesses 
Type D also showed significant interactions with the frequency of i) feeling unwell or run-down 
(X² (4) =9.716, p=.035), ii) suffering a non-serious illness (not requiring a prescription) (X² (4) =12.015, 
p=.013) and iii) illness-related work absences (X² (4) =17.838, p<.001). Type Ds were more likely to have 
felt unwell or run-down ‘frequently’ and were less likely to have ‘never’ suffered a non-serious illness 
or taken time off work. However, Type D category did not relate to the frequency of participants 
suffering an illness requiring prescription medication; X² (4) =2.749, p=.65. 
Healthcare utilisation 
Type D was significantly associated with seeking medical information (without visiting a medical 
professional) (X² (4) =15.444, p=.003). Type D individuals were more likely to have ‘never’, or ‘once or 
twice’ sought medical information. Type D was not related to either frequency of GP (X² (4) =2.781, 
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p=.64) or hospital (X² (3) =3.213, p=.38) visits. (See Table S2 for responses to each retrospective health 
question for Type D and non-Type Ds) 
Discussion 
The current study is the largest to date to i) consider the relationship between Type D and physical 
symptoms in the general population, and ii) investigate differences in aspects of retrospective health 
and healthcare utilization in relation to Type D status. Analyses were conducted using both the 
categorical and dimensional approach to the construct, where possible, as recommended by Ferguson 
et al. (2009). A major strength of the study may be attributed to the longitudinal design, which is 
particularly beneficial in the consideration of the mediating factors. Furthermore, examination of the 
relationships with separate symptom clusters builds on previous work which has considered the 
relationship between Type D personality and a global measure of physical symptoms (Smith et al., 2018; 
Stevenson & Williams, 2014; Williams & Wingate, 2012), and extends our knowledge of the specific 
symptoms associated with Type D. The main findings indicate significant associations between Type D 
personality and particular stress-related symptoms (sympathetic/cardiac, muscular, metabolic, 
vasovagal, and headache). However, these symptoms were also found to be related to levels of NA but 
not SI in isolation. Relatively small relationships between Type D (interaction between SI and NA) and 
an increase in symptoms over the follow-up period were observed. It could therefore be speculated 
that the relationships observed may be predominantly attributed to the effect of negative affect on 
subjective health. This is discussed further with regards to the utility of the Type D construct. 
The prevalence of Type D personality in the current study (45.6% at baseline and 45.0% at follow 
up) is higher than the prevalence rate typically reported in studies in the general population (Mols & 
Denollet, 2010b); however, it is comparable to a number of recent studies undertaken in the UK/Ireland 
(Booth & Williams, 2015; Williams et al., 2008), and Australia (Horwood, Chamravi, & Tooley, 2015). 
This may demonstrate an increase in Type D caseness over time (i.e. due to the pressure of modern 
society) or, speculatively, could be attributed to cultural differences. Further, Type D personality, and 
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its components showed significant stability over the year period, similar to other personality traits such 
as the ‘big five’ (Cobb-Clark & Schurer, 2012).  
With respect to physical symptoms, categorical analyses indicated that Type Ds reported 
significantly greater frequencies of all symptom clusters in comparison to non-Type Ds. Correlational 
analyses also reflected this, demonstrating positive (albeit weak to moderate) relationships between 
Type D scores and the symptom clusters. These findings support previous studies conducted in both the 
general population (Stevenson & Williams, 2014; Williams & Wingate, 2012) and patient populations 
(e.g. Chapman, Duberstein, & Lyness, 2007).  This also indicates that the relationships between Type D 
and physical symptoms exist across both the dichotomous and dimensional conceptualisations of Type 
D. However, in the regression models controlling for SI and NA, Type D was only found to be predictive 
of total symptoms, sympathetic/cardiac, muscular, metabolic, vasovagal, and headache symptoms. 
Stevenson and Williams (Stevenson & Williams, 2014) reported that the synergistic effect of Type D 
personality did not significantly predict physical symptoms when analysed in this way, although with a 
somewhat smaller sample. Our findings with a larger sample indicate that dimensional Type D can 
predict physical symptoms, possibly suggesting the previous study (Stevenson & Williams, 2014) could 
have been underpowered. However, owing to the fact that in the regression models SI did not predict 
any of the outcome variables under investigation here, it is acknowledged that these results 
demonstrate that levels of NA are largely responsible for the relationship. Further, the small Type D 
interaction effects observed here could alternatively be attributed to the possibility of a non-linear 
relationship between NA and symptoms, particularly as physical symptoms tend to be positively-
skewed. This should also be considered when interpreting these findings, particularly with respect to 
the predictive utility of the Type D construct. 
A significant relationship was observed between Type D and sympathetic/cardiac symptoms, 
however again the contribution of social inhibition was minimal. Nevertheless, this finding corresponds 
with the abundance of literature linking Type D personality to adverse cardiovascular outcomes 
(Borkoles, Polman, Ski, & Thompson, 2012; Denollet, 1998a; Howard & Hughes, 2013; Kelly-Hughes et 
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al., 2014; Kupper & Denollet, 2007; Nyklíček, Vorselaars, & Denollet, 2011; Pedersen & Denollet, 2003; 
Sher, 2005). Given this was demonstrated in a healthy population, this may indicate that the influence 
of Type D in cardiac-related health begins to manifest prior to disease onset, supporting existing 
evidence of Type D personality as an independent cardiovascular risk marker (Hausteiner, Klupsch, 
Emeny, Baumert, & Ladwig, 2010). On the other hand, this could simply indicate that high levels of 
negative affect could be particularly detrimental to cardiac health. Either way, this supports previous 
research in which various psychosocial factors have been implicated in the aetiology and pathogenesis 
of cardiovascular disease (CVD) and poor cardiac health (Black & Garbutt, 2002), most notably; acute 
and chronic stress (Lagraauw, Kuiper, & Bot, 2015). Considering the previous links between Type D and 
CVD, in addition to the current finding with regards to cardiac symptoms, it could be postulated that 
stress may play a mediating role in the relationship.  
Further, as stress is associated with various health outcomes, it is likely this theory could explain 
the observed associations with other symptom clusters. For example, the observed relationship 
between Type D and Vasovagal symptoms (e.g. ‘dizziness’) may represent issues with vitality and 
exhaustion. Lack of vitality and exhaustion are issues associated with both acute (Kudielka et al., 2006) 
and chronic (Bellingrath, Weigl, & Kudielka, 2009) stress and are theorised to be underpinned by 
autonomic dysfunction (Hall, Podawiltz, & Mummert, 2012), a problem linked to the body’s inability to 
cope with demands. Furthermore, headaches; which are often attributed to heightened stress levels 
(Björling, 2009), were also found to be predicted by the continuous Type D measure in the current study. 
The relationship observed between Type D and  muscular pain supports similar, albeit solely categorical, 
findings of Condѐn and colleagues (2013) who observed increased musculoskeletal problems in Type D 
adolescents. 
With respect to the stress-related theory; the items on the metabolic symptom factor including 
weight change, poor appetite, and sleep problems, are also associated with prolonged experiences of 
stress (Kim & Dimsdale, 2007; Serlachius, Hamer, & Wardle, 2007) and are common symptoms of 
burnout (Lundgren-Nilsson, Jonsdottir, Pallant, & Ahlborg, 2012). Existing research has demonstrated 
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links between Type D personality and symptoms of burnout and related mental health issues (Geuens, 
Braspenning, Van Bogaert, & Franck, 2015; Ogińska-Bulik, 2006; Polman, Borkoles, & Nicholls, 2010), 
and exemplifies the potential importance of distress in the Type- D health relationship.  
The mediation analyses revealed that Type D scores at baseline significantly predicted metabolic 
symptoms, gastrointestinal, and cold/flu symptoms at follow up, when baseline measures were 
controlled for (in line with recommendations for longitudinal analyses). This suggests that Type D 
personality may lead to a deterioration in health via these symptom clusters over time. However, the 
large contribution of NA to these relationships should be highlighted. With respect to the observed 
relationship with gastrointestinal symptoms, previous studies have also found links between Type D and 
poorer outcomes (i.e. increased symptom severity and lower quality of life) in patients with functional 
gastrointestinal disorders (Hansel et al., 2010), and irritable bowel syndrome (Sararoudi et al., 2011). As 
for cold and flu like symptoms, it is well established that these types of symptoms often manifest in viral 
respiratory infections as a consequence of a dampened immune system (Kelly & Busse, 2008). Lowered 
immune response has been found to  be exacerbated by increased stress and maladaptive stress 
response via increases in cortisol (Kiecolt-Glaser et al., 1987; Smolderen, Vingerhoets, Croon, & 
Denollet, 2007) which may further indicate the possibility of a stress-related mechanism underpinning 
the Type D-health relationship. Cold and flu symptoms are however, also associated with inflammatory 
allergies such as hay fever and asthma (Ciprandi et al., 2005). Therefore, it could be suggested that the 
effects of Type D personality may extend to abnormalities with inflammatory processes. This notion has 
previously been evidenced in cardiac populations (Denollet et al., 2009), however, further research in 
non-cardiac populations, as well as healthy individuals is required. 
Unsurprisingly, Type D individuals reported significantly greater levels of perceived stress than 
their non-type D counterparts, which replicates similar studies examining perceived stress in Type D 
individuals (Habra et al., 2003; Kelly-Hughes et al., 2014; Ogińska-Bulik, 2006; Polman et al., 2010). 
However, analyses indicated that baseline measures of perceived stress did not significantly predict 
metabolic, gastrointestinal or cold/flu symptoms. Stressful life events, on the other hand, were related 
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to these symptoms, and mediation analyses indicated partial mediation via stressful life events between 
Type D and metabolic and gastrointestinal symptoms. These findings indicate that Type D personality is 
associated with an increased likelihood of experiencing stressful life events, which in turn enhances the 
likelihood of experiencing these symptoms. It could be suggested that Type D individuals may be more 
likely to experience or classify an event as stressful due to their propensity to negative emotions. The 
link between stressful life events and these symptoms supports research demonstrating associations 
between increased stress and metabolic problems (e.g. poor appetite, sleep problems and fatigue; Kim 
& Dimsdale, 2007; Serlachius et al., 2007) and gastrointestinal illnesses such as IBS (Pract, 2016) further 
exemplifying the role of stress in the relationship between Type D personality and poor health 
outcomes.  
These findings are not entirely surprising, given the large body of literature linking NA (and 
neuroticism) to both distress and negative health outcomes (e.g. Watson & Pennebaker, 1989, Cohen 
et al., 1995). Further, this leads to speculation regarding the fully interactive effect of Type D, and the 
influence of social inhibition on health related outcomes. While correlations were observed between SI 
and the majority of outcomes in the current study, SI was not a significant predictor of any symptoms 
in the first step of the regression analyses. A potential explanation for these seemingly contradictory 
findings is conceptual overlap between NA and SI, particularly given the high correlation between these 
variables at both time points.   
Type D personality was also found to be associated with higher levels of anxiety in the current 
study, and anxiety fully mediated the relationship between Type D personality and metabolic 
symptoms. This supports previous findings which have demonstrated links between anxiety and 
increased somatic symptoms (Haug, Mykletun, & Dahl, 2004) and Type D personality (e.g. Pedersen, van 
Domburg, Theuns, Jordaens, & Erdman, 2004) and seems logical given that metabolic symptoms (e.g. 
feeling low in energy, poor appetite) are related to stress and burnout, which in turn are linked to Type 
D personality (Ogińska-Bulik, 2006).  
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Levels of depression were also associated with Type D, however they were not found to mediate 
any of the relationships between Type D and the symptom clusters in the current study. As the 
prevalence of depression is well-documented in the Type D and cardiovascular disease literature (Barth, 
Schumacher, & Herrmann-Lingen, 2004; De Voogd et al., 2009; Grande, Romppel, & Barth, 2012) it was 
assumed that depression may be involved in the relationship between Type D and general ill health. 
However, given these findings in healthy individuals, it could be suggested that depression may emerge 
in Type D individuals as a risk factor for poorer health outcomes in the later stages of illness.  
With further regards to these mediation analyses, it must be acknowledged that negative affect, 
stress, depression, and anxiety are not entirely distinct constructs, but are in fact very closely related 
measures of psychological morbidity (e.g. Clara, Cox, & Enns, 2001; Haug, Mykletun, & Dahl, 2004). 
Given the overlap between these constructs, it may be expected that the findings would be highly 
similar for each of the different mediators. However, this was not the case, as mediation by the 
psychological morbidity variables emerged for some of the physical symptoms but not others, and the 
mediation models revealed different mediation effects for each of the psychological morbidity 
variables. Of course, the issue remains that Type D and other measures of psychological morbidity are 
difficult to disentangle, and the outcomes of the mediation analyses should be interpreted in this 
context.  
Finally, in terms of retrospectively reported health, categorical findings indicated that Type D 
participants were more likely to rate their health as poorer, and be more dissatisfied with their current 
health status. Those classified as Type D were also more likely to experience feeling unwell or run down, 
suffer non-serious illnesses and be absent from work due to sickness. These findings correspond with 
the findings of a meta-analysis (Mols & Denollet, 2010b) demonstrating links between Type D and both 
poorer health status and increased work-related issues (e.g. absenteeism). In the current study, Type D 
individuals were also less likely to have sought medical advice in the past year.  Given their high levels 
of social inhibition, this may suggest a preference to seek out medical information from other sources; 
however, this requires further investigation. No differences were observed with regards to medication 
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use, GP visits, or hospital attendance between Type Ds and non-Type Ds. However, as Type Ds reported 
more minor illnesses, these findings in combination may further suggest that Type D individuals are less 
likely to seek treatment when they are unwell.  On the other hand, it could also be proposed that Type 
D individuals have an increased sensitivity to sensations attributed to certain symptoms (Cohen et al., 
1995), hence the increased reporting of illnesses. However, if the theory that they tend to avoid medical 
advice holds true, then it may be the case that Type Ds neglect to report those more serious illnesses 
which may require treatment. Again, this requires further investigation. 
The current study has a number of strengths. The study had a reasonably large sample from the 
general population which was not limited to undergraduate students or the UK/Ireland population and 
therefore results are more generalizable in comparison to similar recent studies (e.g. Polman et al., 
2010; Stevenson & Williams, 2014). Furthermore, the use of a dimensional conceptualisation of Type D 
in addition to the traditional categorical approach, offered a more rigorous approach to analysis in 
comparison to earlier studies (Stevenson & Williams, 2014). The use of multiple regression analyses 
allowed for the statistical control of the independent effects of NA and SI, which is particularly important 
given the well documented links between negative emotions and physical health, as discussed.  
The longitudinal design is a further strength, which has enabled the advancement of knowledge 
regarding the links between Type D personality and health including a clearer picture of the 
directionality of the relationships identified (Farrington, 1991).  The longitudinal design has also 
facilitated the investigation of changes in perceived health status and healthcare utilisation over a year 
period, in Type D individuals, which extends previous cross-sectional work (Chapman et al., 2007; 
Jellesma, 2008; Michal et al., 2011; Stevenson & Williams, 2014).  This is a particular benefit as very few 
previous Type D studies in the general population have implemented a longitudinal design in the past.  
The online data collection methodology was particularly useful for recruiting large numbers of 
participants at both baseline and the follow up, as completion could be executed entirely remotely. 
Nevertheless, the follow up did suffer a 70% attrition rate. Online data collection can increase 
perceptions of privacy, and encourage participants to disclose more information (Branley, Covey, & 
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Hardey, 2014). Therefore, given the social inhibitory nature of Type Ds (Denollet, 2005), online 
recruitment is particularly useful for recruiting individuals from this population. This could also explain 
the prevalence of Type D participants in the current study. Finally, this data collection method also 
enabled the monitoring of the timeframe in which participants completed the follow-up, which ensured 
relative consistency in the interval between the collection of baseline and follow-up data.  
Nonetheless, there are a number of limitations associated with the use of online data collection 
methods, including confinement of participation to internet users only. Online studies also often attract 
larger proportions of females and younger participants (Lefever, Dal, & Matthíasdóttir, 2007) which is 
reflected in the large proportion of females and relatively low mean age of the sample in the current 
study. Although research suggests females are more likely to report somatic symptoms (Gijsbers Van 
Wijk & Kolk, 1997), the prevalence of Type D personality does not greatly differ between males and 
females, therefore limiting the issues of the gender imbalance (Mols et al., 2012).  
However, in the current study a larger percentage (~8-10% more) of males were classified as Type 
D at both baseline and follow up.  This does not reflect the general finding that females tend to report 
higher levels of negative affect (e.g. Watson & Pennebaker, 1989), and is also somewhat dissimilar to a 
sample of the general population from Germany in which a marginally higher percentage of females 
(31.6% compared to 30.6% of males) were classified as Type D (Grande et al., 2010). This could perhaps 
be due to a higher prevalence of social inhibition in males, particularly in the UK where the majority of 
the current participants resided. Alternatively, given their social inhibition, the anonymity of the current 
online method of data collection may have attracted more Type D males, due to the fact they could 
participate while avoiding social interaction. 
Further limitations include the general issues that arise with the reliance on subjective measures, 
such as the risk of self-report biases and social desirability. However, self-report methodology still 
maintains substantial merit and is regarded as a reliable technique for assessing perceived health and 
physical symptoms (Cella et al., 2010) Further, with regards to the symptom perception hypothesis 
(Watson & Pennebaker,1989), it must also be considered that distress can influence perceptions of 
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health  (Farmer & Ferraro, 1997; Tessler & Mechanic, 1978), and in turn self-reported health outcomes. 
Self-reported health impairments may therefore be exaggerated in Type D individuals, given their 
predisposition to negative emotions (Benham, 2006). This is an issue with most Type D health research 
utilising self-report measures, and must be considered in the interpretation of these findings.  
Furthermore, although the inclusion of retrospective health questions was beneficial in 
complementing the assessment of physical symptoms in the current study, retrospective health 
information is considered less reliable relative to prospective or ambulatory self-report methods (Taffe 
& Dennerstein, 2000) and causality cannot be reliably inferred. Therefore, future research may wish to 
gauge long term health by requiring regular prospective or ambulatory health assessments over the full 
study period. Finally, the follow up period of one year was a reasonably short timeframe for 
investigating the development of poor health in generally healthy individuals. Therefore, it is suggested 
that implementation of a longer follow-up period in future studies may aid in extending our 
understanding of the development of physical symptoms in relation to Type D personality. Further, in 
light of the findings signifying the stress-related nature of symptoms that appear to be related to aspects 
of Type D personality, it is suggested that objective measures of stress and health (e.g. sympathetic 
activation, cortisol and levels of inflammation) should be explored in future studies, to aid in 
understanding the psychobiological mechanisms underpinning these relationships. 
Finally, there is some debate as to whether the Type D construct can adequately explain health 
related variables over and above other personality factors (e.g. neuroticism from the ‘big five’). Studies 
are still emerging in the literature which support a role for the NA x SI interaction as a predictor of 
numerous health outcomes (e.g. Howard & Hughes, 2011). However, it has also been suggested that 
NA and SI may be better represented by neuroticism and extraversion, given the superior psychometric 
evidence that exists to support the validity of these constructs (Howard & Hughes, 2011; Horwood & 
Anglim, 2017). Another thing to consider with regards to the association between aspects of personality 
and health variables is the influence of conscientiousness, given its emergence in the literature as an 
important predictor of health status (Bogg & Roberts, 2004).  
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In summary, the current study has provided evidence that Type D personality may predict 
particular symptoms which are often associated with heightened stress. These findings extend previous 
cross-sectional work in healthy individuals, and provide some prospective evidence that links between 
Type D and physical symptom clusters exist, although the precedence of NA as the primary contributing 
factor must be acknowledged. The predictive ability of Type D (NAxSI interaction) for stress-related 
symptoms has been shown to augment, albeit marginally, the influence of NA in isolation on aspects of 
subjective health. However, as mentioned above, the findings should be interpreted in the context of 
the various criticisms of the Type D construct, including suggestions that effects are primarily driven by 
NA. Anxiety and stressful life events were found to play mediating roles in the relationships with and 
both metabolic and gastrointestinal symptoms, which may exemplify the importance of stress and 
distress in the Type D-health relationship. Given the aforementioned overlap in general psychological 
morbidity between the constructs being investigated as mediating variables here, further work is 
warranted to elucidate the mechanisms underpinning the relationship between Type D personality and 
physical health outcomes. Finally, retrospective assessment of health status and healthcare utilisation 
indicated that individuals categorically defined as Type D report poorer health status, increased minor 
illness and work absences, but are less likely to seek medical information. 
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TABLES 
 
Table 1. Participant demographic and Type D data 
 N Age Gender  Type D category  Continuous Type D scores 
  M (SD) Males 
n(%) 
Females 
n(%) 
 Type D 
n(%) 
Non Type D 
n(%) 
 SI  
M(SD) 
NA  
M(SD) 
Type D  
M(SD) 
Baseline 535 29.80 (12.90) 
104 (19.4%) 
51.9% Type D 
431 (80.6%) 
44.1% Type D 
 244 (45.6%) 291 (54.4%)  11.38(6.33) 12.33(6.33) 149.77(126.72) 
Follow-up 160 34.05 (13.71) 
33 (20.6%) 
50.4% Type D 
127 (79.4%) 
41.7% Type D 
 72 (45.0%) 88 (55.0%)  11.69 (6.91) 12.38 (6.81) 157.84 (149.24) 
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Table 2. Correlations between baseline measures of Type D, anxiety, depression, perceived stress and total symptoms with measures at follow-up including mean scores 
[SD] (N=160). 
   Follow up Mean [SD] 
 Measures SI NA Type D Symptoms Anxiety Depression 
Perceived 
Stress 
Life 
events 
 Total Males Females 
B
as
e
lin
e
 
SI .857** .400** .713** .283** .306** .405** .400** .021  
11.69 
[6.91] 
13.39 
[6.36] 
11.25 
[7.00] 
NA .329** .837** .605** .513** .664** .496** .626** .271**  
12.38 
[6.81] 
12.73 
[6.73] 
12.29 
[6.85] 
Type D  .652** .673** .809** .502** .555** .509** .611** .180*  
157.84 
[149.24] 
177.47 
[151.54] 
152.86 
[148.85] 
Symptoms  .2418* .562** .427** .750** .678** .419** .505** .407**  
17.30 
[15.58] 
14.33 
[13.85] 
18.07 
[15.96] 
Anxiety  .237** .692** .457** .609** .766** .489** .594** .471**  
8.49 
[4.25] 
8.12 
[4.39] 
8.52 
[4.28] 
Depression  .395** .566** .526** .374** .501** .703** .543** .326**  
4.15 
[3.44] 
4.91 
[3.69] 
3.92 
[3.36] 
Perceived Stress  .348** .601** .587** .421** .482** .475** .604** .231**  
17.31 
[7.78] 
15.58 
[7.04] 
17.36 
[8.10] 
M
ea
n
 [
SD
] Total (n=160) 
11.40   
[6.46] 
12.48 
[6.43] 
148.88 
[128.47] 
17.90 
[16.20] 
7.60 
[4.82] 
3.96 
[3.63] 
16.86 
[7.81] 
192.85 
[130.18] 
    
Male (n= 33) 
13.03 
[6.05] 
13.15 
[5.99] 
168.66 
[124.64] 
14.61 
[12.72] 
6.82 
[3.67] 
4.24   
[3.58] 
16.18 
[6.88] 
162.33 
[110.15] 
    
Females (n= 127) 
10.98 
[6.52] 
12.31 
[6.55] 
143.82 
[129.43] 
18.76 
[16.93] 
7.74 
[5.10] 
3.86   
[3.66] 
16.90 
[8.16] 
196.22 
[136.13] 
    
*p<0.05; **p<0.001 
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Table 3. Baseline analyses for the measures of anxiety, depression, perceived stress and physical symptom clusters; i) independent samples t-tests indicating differences 
between Type D groups (Mean [±SD]) and; ii) Pearson’s correlations with continuous SI, NA and Type D scores (N= 535). 
 Between groups  Correlations 
Measures Non-Type D  Type D  t df p d  SI NA Type D M SD 
Anxiety 7.16 (3.54) 10.30 (3.74) -9.930 532 <.001** .861  .305** .683** .492** 8.59 3.95 
Depression 2.92 (2.71) 5.57 (3.38) -10.050 530 <.001** .873  .385** .547** .502** 4.13 3.31 
Perceived Stress  
 
15.72 (6.41) 22.07 (6.36) -11.331 522 <.001** .981  .383** .672** .556** 18.55 7.06 
Total symptoms 14.64(14.54) 21.84 (16.27) -5.407 533 <.001** .468  .186** .448** .369** 17.93 15.75 
Cardiac/sympathetic 1.69 (3.83) 2.75 (4.02) -3.126 533 .002* .271  .117** .290** .235** 2.18 3.95 
Muscular 2.34 (3.25) 3.71 (4.27) -4.217 533 <.001** .365  .156** .292** .273** 2.96 3.81 
Metabolic 4.48 (4.09) 6.63 (4.51) -5.763 533 <.001** .500  .184** .481** .361** 5.46 4.41 
Gastrointestinal 1.64 (2.99) 2.36 (2.92) -2.782 533 .006* .241  .065 .247** .193** 1.97 2.98 
Vasovagal 1.22 (2.42) 1.98 (2.82) - 3.349 533 .001** .290  .150** .325** .294** 1.57 2.63 
Cold 1.78 (2.12) 2.16 (2.29) -1.976 533 .049** .171  .095* .220** .147** 1.96 2.20 
Headache 1.18 (1.55) 1.94 (2.14) -4.774 533 <.001 .414  .165** .318** .311** 1.52 1.88 
*p<0.05; **p<0.001 
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Table 4. The relationship between Type D at baseline (path c) and each symptom cluster at follow up controlling for 
baseline symptoms (N=158). 
 Total effect (path c)  
Factor                      β SE  t p 
Total Symptoms .0138 .0079 1.744 .083 
Cardiac .0047 .0038 1.230 .22 
Metabolic .0047 .0019 2.430 .016* 
Muscular pain .0014 .0017 0.810 .42 
Gastro .0058 .0017 3.465 <.001** 
Vasovagal .0008 .0013 0.596 .55 
Cold/Flu .0025 .0009 2.690 .008* 
Headaches .0006 .0009 0.704 .48 
**p<.001, *p<.05 
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Table 5. Mediation between Type D and metabolic, gastrointestinal and cold/flu symptoms by PSS, anxiety, depression and stressful life events (N=158) 
  Relationship between mediator 
and symptom  (path b) 
 Direct effect (c’path) 1  Indirect effect (a*b) 2 
Symptoms Mediator β SE  p  β SE  p LLCI ULCI  β SE  LLCI ULCI 
Metabolic Anxiety .2662 .0837 .002  .0028 .0018 .13ᵃ -.0008 .0064  .0041 .0013 .0017 .0070 
 Depression -.0503 .1120 .65  .0051 .0023 .027 .0006 .0097  -.0007 .0015 -.0037 .0023 
 Perceived stress  .0428 .0466 .36  .0037 .0022 .091 -.0006 .0080  .0013 .0015 -.0011 .0048 
 Life events .0041 .0017 .017  .0046 .0019 .015ᵇ .0009 .0082  .0006 .0004 .0001 .0020 
Gastro- 
intestinal 
Anxiety .0604 .0720 .40  .0050 .0020 .013 .0011 .0090  .0009 .0010 -.0012 .0028 
Depression .0666 .0796 .40  .0049 .0021 .019 .0008 .0090  .0009 .0011 -.0012 .0031 
 Perceived stress  -.0170 .0437 .69  .0063 .0025 .012 .0014 .0112  -.0005 .0011 -.0025 .0015 
 Life events .0029 .0013 .034  .4068 .1454 .006ᵇ .0021 .0087  .0004 .0003 .0000 .0014  
Cold/flu Anxiety .0455 .0436 .29  .0018 .0012 .13 -.0005 .0042  .0007 .0006 -.0004 .0021 
 Depression -.0903 .0442 .043  .0037 .0011 .002 .0014 .0059  -.0012 .0006 -.0025 -.0001 
 Perceived stress  .0454 .0267 .090  .0011 .0013 .40 -.0014 .0036  .0014 .0008 .0000 .0032 
 Life events .0016 .0011 .15  .0021 .0009 .019 .0003 .0039  .0003 .0002 .0000 .0010 
1 c’ path is the relationship between Type D and the symptom when the mediator is included in the model. ᵃFull mediation.  ᵇPartial mediation. 
2The indirect (mediation) effect is significant if the bootstrapped confidence intervals do not include 0.  
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FIGURES 
 
 
 
Figure 1. Non-mediated (a) and mediated (b) pathways between Type D personality and physical 
symptoms (each symptom cluster was considered in a separate statistical model). Path c’ represents the 
direct effect of Type D personality on physical symptoms with the mediator included in the model. The 
indirect effect is the product of path a and path b. Each mediator was considered in a separate statistical 
model. All models controlled for the baseline symptom score in model of Y only. 
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APPENDIX 
Appendix A - Retrospective Health Questions 
1) How is your health in general right now, would you say it was: 
- Very Good 
- Good 
- Fair 
- Bad 
- Very Bad 
2) Over the last 12 months would you say your health has, on the whole, been ...: 
- Very Good 
- Good 
- Fairly good 
- Not very good 
- Not good at all 
3) Compared to one year ago, how would you say your health is now? 
- Much better now than 1 year ago 
- Somewhat better now  
- About the same as 1 year ago 
- Somewhat worse now  
- Much worse now  
4) How satisfied are you with your health in general? 
- Very satisfied 
- Satisfied 
- Neither satisfied nor dissatisfied 
- Dissatisfied 
- Very dissatisfied 
5) During the last year, approximately how often have you felt generally ill, unwell or run down (due to 
tiredness, fatigue, stress etc.)? 
- Never 
- Rarely 
- Sometimes 
- Frequently 
- Always 
6) During the last year, approximately how often have you suffered a non-serious illness such as a cold, 
stomach bug or minor infection which has not required prescription medication? 
- Never 
- Once or twice 
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- Three or four times 
- Five or six times 
- More than six times 
7) During the last year, approximately how often have you suffered a more serious illness which has 
required prescription medication (e.g. antibiotics, steroidal medication)? 
- Never 
- Once or twice 
- Three or four times 
- Five or six times 
- More than six times 
8) During the last year, approximately how frequently have you had to take time off work due to illness? 
- Never 
- Once every 3-4 months 
- Once every 2-3 months 
- approximately once per month 
- More than once per month 
- Not applicable (if retired/un-employed/maternity leave etc) 
9) During the last year, approximately how regularly have you visited your GP or other healthcare 
profession (e.g. district nurse, walk-in-centre) because of a health problem?  
- Never 
- Once every 3-4 months 
- Once every 2-3 months 
- Approximately once per month 
- More than once per month 
10) During the last year, approximately how regularly have you sought medical information about a 
problem with your health without visiting a medical professional (e.g. via telephone, post or email, health 
leaflets, online health information websites)? 
- Never 
- Once every 3-4 months 
- Once every 2-3 months 
- approximately once per month 
- More than once per month 
11) During the last year, have you ever been admitted to hospital? 
- Never been in hospital 
- Yes, On 1 occasion I have been in hospital for treatment as a day-patient 
- Yes, On 1 occasion I have been in hospital as an inpatient and stayed overnight or longer  
- Yes, On multiple occasions I have been in hospital for treatment as a day-patient 
- Yes, On multiple occasions I have been in hospital as an inpatient and stayed overnight 
or longer 
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SUPPLEMENTARY MATERIAL 
 
Table S1 – Table of hierarchical multiple regression analyses demonstrating the prediction of self-reported 
physical symptoms at baseline by SI, NA and Type D (N=535). 
Symptom   B SE b β t p R² (ΔR²) 
Total 
symptoms 
Step 1 SI -.066 .111 -.026 -.597 .55  
 NA 1.154 .109 .458 10.623 <.001 .200** 
Step 2 SI -.631 .223 -.244 -.2832 .005  
  NA .679 .195 .269 3.475 .001  
  Type D .045 .015 .361 2.917 .004 .213 (.013**) 
Sympathetic
/Cardiac 
Step 1 SI -.016 .030 -.025 -.542 .59  
 NA .181 .029 .289 6.248 <.001 .078** 
Step 2 SI -.141 .059 -.220 -2.373 .018  
  NA .075 .052 .121 1.447 .15  
  Type D .010 .004 .323 2.422 .016 .088(.010*) 
Muscular Step 1 SI .016 .028 .025 .554 .58  
  NA .172 .028 .288 6.255 <.001 .089** 
 Step 2 SI -.094 .057 -.153 -1.661 .097  
  NA .080 .050 .133 1.608 .11  
  Type D .009 .004 .296 2.230 .026 .098 (.009*) 
Metabolic Step 1 SI -.038 .031 -.053 -1.243 .22  
  NA .346 .030 .491 11.543 <.001 .222** 
 Step 2 SI -.148 .062 -.205 -2.401 .017  
  NA .254 .054 .359 4.681 <.001  
  Type D .009 .004 .252 2.054 .041 .228 (.006*) 
Gastro-
intestinal 
Step 1 SI -.028 .023 -.057 -1.217 .22  
 NA .133 .022 .277 5.959 <.001 .067** 
 Step 2 SI -.104 .046 -.212 -.2.262 .024  
  NA .069 .040 .144 1.708 .088  
  Type D .006 .003 .256 1.908 .057 .073 (.006) 
Vasovagal Step 1 SI .002 .020 .004 .086 .93  
  NA .139 .019 .328 7.206 <.001 .109 
 Step 2 SI -.097 .040 -.223 -2.446 .015  
  NA .056 .035 .132 1.616 .11  
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  Type D .008 .003 .375 2.866 .004 .122(.014**) 
Cold/Flu Step 1 SI -.006 .017 -.015 -.329 .74  
  NA .078 .017 .221 4.696 <.001 .046** 
 Step 2 SI .019 .034 .053 .561 .58  
  NA .099 .030 .280 3.287 .001  
  SI × NA -.002 .002 -.114 -.834 .41 .047(.001) 
Headache Step 1 SI .011 .014 .036 .797 .43  
  NA .096 .014 .316 6.953 <.001 .111** 
 Step 2 SI -.059 .028 -.192 -2.105 .036  
  NA .036 .025 .120 1.463 .14  
  Type D .006 .002 .377 2.882 .004 .125(.014**) 
*p<0.05; **p<0.01 B = unstandardized beta, SE b = standard error of unstandardized beta, β = standardised beta, 
R² = R-squared, ΔR² = R-squared change. 
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Table S2 – Table showing number (%) of responses to each retrospective health question 
Question Response Non-Type D  Type D Total 
 
Perception of current 
health 
 
Very good 
 
28 (17.7%) 
 
9 (5.7%) 
 
37 (23.4%) 
Good 42 (26.6%) 34(21.5%) 76 (48.1%) 
Fair 14 (8.89%) 24 (15.2%) 38 (24.1%) 
 Bad 2 (1.3%) 4(2.5%) 6 (3.8%) 
 Very Bad 0 (0.0%) 1 (0.6%) 1 (0.6%) 
Perception of health 
over past year 
Very good 32 (20.3%) 13 (8.2%) 45 (28.5%) 
Good 37 (23.4%) 33 (20.9%) 70 (44.3%) 
Fair 14 (8.9%) 19 (12.0%) 33 (20.9%) 
Not very good 2 (1.3%) 7 (4.4%) 9 (5.7%) 
 Not good at all 1 (0.6%) 0 (0.0%) 1 (0.6%) 
Change in health over 
past year 
Much better 10 (6.4%) 2 (1.3%) 12 (7.6%) 
Somewhat better 14 (8.9%) 20 (12.7%) 34 (21.7%) 
About the same 44 (28.0%) 36 (22.9%) 80 (51.0%) 
Somewhat worse 16 (10.2%) 14 (8.9%) 30 (19.1%) 
Much worse 1 (0.6%) 0 (0.0%) 1.0 (0.6%) 
Satisfaction with their 
current health status 
Very Satisfied 20 (12.7%) 13 (8.2%) 33 (20.9%) 
Satisfied 44 (27.8%) 24 (15.2%) 68 (43.0%) 
Neither  8 (5.1%) 11 (7.0%) 19 (12.0%) 
Dissatisfied 13 (8.2%) 22 (13.9%) 35 (22.2%) 
Very Dissatisfied 1 (0.6%) 2 (1.3%) 3 (1.9%) 
Frequency of feeling 
unwell or run-down 
All the time 3 (1.9%) 3 (1.9%) 6 (3.8%) 
Frequently 14 (8.9%) 22 (13.9%) 36 (22.8%) 
Sometimes 35 (22.2%) 33 (20.9%) 68 (43.0%) 
Rarely  32 (20.3%) 14 (8.9%) 46 (29.1%) 
Never 2 (1.3%) 0 (0.0%) 2 (1.3%) 
Frequency of suffering 
a non-serious illness 
Seven or more times 1 (0.6%) 3 (1.9%) 4 (2.5%) 
Five or six times 8 (5.1%) 12 (7.6%) 20 (12.7%) 
Three or four times 21 (5.1%) 22 (13.9%) 43 (27.2%) 
Once or twice 43 (27.2%) 34 (21.5%) 77 (48.7%) 
Never 13 (8.2%) 1 (0.6%) 14 (8.9%) 
Seven or more times 1 (0.6%) 0 (0.0%) 1 (0.6%) 
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Frequency of illnesses 
requiring prescription 
medication 
Five or six times 1 (0.6%) 3 (1.9%) 4 (2.5%) 
Three or four times 3 (1.9%) 3 (1.9%) 6 (3.8%) 
Once or twice 30 (19%) 28 (17.7%) 58 (36.7%) 
Never 51 (32.3%) 38 (24.1%) 89 (56.3%) 
Frequency of work 
absences 
Very frequently 0 (0.0%) 3 (1.9%) 3 (1.9%) 
Quite regularly 0 (0.0%) 1 (0.6%) 1 (0.6%) 
A few times 7 (4.5%) 12 (7.6%) 19 (12.1%) 
Once or twice 35 (22.3%) 27 (17.2%) 62 (39.5%) 
Never 42 (26.8%) 21 (13.4%) 63 (40.1%) 
Frequency of GP visits Very frequently 1 (0.6%) 1 (0.6%) 2 (1.3%) 
Quite regularly 2 (1.3%) 5 (3.2%) 7 (4.4%) 
A few times 20 (12.7%) 15 (9.5%) 35 (22.2%) 
Once or twice 42 (26.6%) 30 (19.0%) 72 (22.2%) 
Never 21 (13.3%) 21 (13.3%) 42 (26.6%) 
Seeking medical 
information 
Very frequently 2 (1.3%) 4 (2.5%) 6 (3.8%) 
Quite regularly 8 (5.1%) 9 (5.7%) 17 (10.8%) 
A few times 17 (10.8%) 17 (10.8%) 34 (21.5%) 
Once or twice 19 (12.0%) 29 (18.4%) 48 (30.4%) 
Never 40 (25.3%) 13 (8.2%) 53 (33.5%) 
Frequency of hospital 
visits 
Multiple, as inpatient  0 (0.0%) 0 (0.0%) 0 (0.0%) 
Multiple, day-patient  1 (0.6%) 4 (2.5%) 5 (3.2%) 
Once, as inpatient 5 (3.2%) 2 (1.3%) 7 (4.4%) 
Once, as day-patient 11 (7.0%) 9 (5.7%) 20 (12.7%) 
Never 69 (43.7%) 57 (36.1%) 126 (79.7%) 
 
